PlainPharmaWatch

CMS Open Payments · Tool

Sequence LifeScience, Inc vs Carestream Health, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Sequence LifeScience, Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 7,391, versus 6,080 for the other company. Its single largest recorded recipient represents 84.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Sequence LifeScience, Inc
HHI 7,391 · top recipient 84.6%
Ranked #211 of 1,838 companies by HHI
Carestream Health, Inc.
HHI 6,080 · top recipient 76.7%
Ranked #263 of 1,838 companies by HHI

Payment Overview

Total Payments
$194.5K
% of Industry
0.0%
Transactions
64
Avg per Transaction
$3.0K
Recipients
64
Avg per Recipient
$3.0K
Payment Types
1
Top Payment Type
Consulting Fee
Total Payments
$193.5K
% of Industry
0.0%
Transactions
27
Avg per Transaction
$7.2K
Recipients
21
Avg per Recipient
$9.2K
Payment Types
4
Top Payment Type
Long-Term Medical Supply or Device Loan

Highlighted values indicate the higher figure for each metric.

Total payments compared

Sequence LifeScience, Inc vs Carestream Health, Inc. - total reported payments in CMS Open Payments PY2024

Sequence LifeScience, Inc$194.5KCarestream Health, Inc.$193.5K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Sequence LifeScience, Inc

Consulting Fee $194.5K

100.0%

Carestream Health, Inc.

Long-Term Medical Supply or Device Loan $64.6K

76.7%

Consulting Fee $18.4K

21.8%

Travel and Lodging $867.00

1.0%

Food and Beverage $392.71

0.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Sequence LifeScience, Inc

  1. 1

    MICHAEL BAUER

    $164,500.00 · 52 txns

  2. 2

    WALTER STRASH

    $30,000.00 · 12 txns

Carestream Health, Inc.

  1. 1

    Northwestern Memorial Hospital

    $64,619.00 · 1 txns

  2. 2

    ELIOT LAWRENCE SIEGEL

    $10,750.00 · 1 txns

  3. 3

    MARCO ERTREO

    $3,750.00 · 1 txns

  4. 4

    BRITTANY M CLOUD

    $2,009.44 · 4 txns

  5. 5

    GREGORY DIEUDONNE

    $1,898.00 · 2 txns

Summary Comparison

Metric Sequence LifeScience, Inc Carestream Health, Inc.
Total Payments $194.5K $193.5K
% of Industry Total 0.0% 0.0%
Transaction Count 64 27
Avg per Transaction $3.0K $7.2K
Recipient Count 64 21
Avg per Recipient $3.0K $9.2K
Payment Type Count 1 4
Top Payment Type Consulting Fee Long-Term Medical Supply or Device Loan

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.